甲状腺嗜酸性细胞癌伴对侧恶性胸腔积液
Hürthle cell carcinoma of the thyroid with contralateral malignant pleural effusion.
作者信息
Hsu Kuo-Feng, Hsieh Chung-Bao, Duh Quan-Yang, Chien Chih-Feng, Li Heng-Sheng, Shih Ming-Lang
机构信息
Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, No. 325 Cheng-Kung Road Sec 2, Neihu, Taipei, Taiwan, Republic of China.
出版信息
Onkologie. 2009 Feb;32(1-2):47-9. doi: 10.1159/000184743. Epub 2009 Jan 20.
BACKGROUND
Thyroid cancers with pulmonary metastases have been well documented. However, malignant pleural effusion has rarely been reported.
CASE REPORT
We present a 77-year-old patient who had Hürthle cell carcinoma of the thyroid with contralateral malignant pleural effusion. The diagnosis was based on consistency in the histopathological and immunohistochemical features of pleural fluid cytology and the final pathology of the thyroid tumor.
RESULTS
The patient was treated with total thyroidectomy and postoperative radioactive-iodine ablation. Unfortunately, he died for recurrent pleural effusion and pulmonary complication 6 months later.
CONCLUSION
Identifying the origin of malignant pleural effusion is important to provide treatment guidance. In this report, we review the literature on diagnosis and treatment of thyroid cancer with malignant pleural effusion.
背景
甲状腺癌伴肺转移已有充分记录。然而，恶性胸腔积液很少被报道。
病例报告
我们报告一名77岁的患者，患有甲状腺嗜酸性细胞癌并伴有对侧恶性胸腔积液。诊断基于胸腔积液细胞学的组织病理学和免疫组织化学特征与甲状腺肿瘤最终病理结果的一致性。
结果
患者接受了甲状腺全切除术及术后放射性碘消融治疗。不幸的是，6个月后他因复发性胸腔积液和肺部并发症死亡。
结论
确定恶性胸腔积液的来源对于提供治疗指导很重要。在本报告中，我们回顾了关于甲状腺癌伴恶性胸腔积液诊断和治疗的文献。
Zotero 插件